However, LAPTM4B *2 is significantly associated with tumor recurrence, poor histopathologic differentiation, higher TNM stage and presence of portal vein invasion which argues that it is a driver of hepatocellular carcinoma and therefore warrants further investigation. This evidence concerns the gene LAPTM4B and hepatocellular carcinoma.